Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA (FMCQF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
fmcqf · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Hold
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $45.17
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $46.61 | ↑ 3.20% |
1-day model range: $46.48–$46.75. Peak: $46.75 (+3.20%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $46 | +1.9% |
| 2028 | $47 | +3.1% |
| 2029 | $47 | +3.9% |
| 2030 | $47 | +4.4% |
| 2031 | — | +4.8% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FMCQF · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-10-10 | Truist Securities | Maintains | Hold→Hold |
| 2023-07-12 | Truist Securities | Maintains | Hold→Hold |
| 2023-05-09 | Truist Securities | Maintains | Hold→Hold |
| 2023-04-12 | Truist Securities | Maintains | Hold→Hold |
| 2023-02-22 | Truist Securities | Maintains | Hold→Hold |
| 2022-06-21 | Truist Securities | Maintains | Hold→Hold |
| 2021-11-16 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2021-11-10 | Jefferies | Upgrade ↑ | Underperform→Hold |
| 2020-05-20 | SunTrust Robinson Humphrey | Maintains | Buy→Buy |
| 2020-05-10 | SunTrust Robinson Humphrey | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Fresenius Medical Care AG & Co. KGaA (FMCQF) stock. Of the recent 31 rating actions, 11 were upgrades and 8 were downgrades. 16 analysts currently cover FMCQF.
Analyst Recommendation Trends
FMCQF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$19.5B
↓ 7.1% YoY
Revenue Next Year
$20.1B
↑ 3.4% YoY
EPS This Year
$4.05
EPS Next Year
$4.38
↑ 8.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast FMCQF EPS of $4.05 for the current fiscal year, based on estimates from 1 analysts. The FMCQF revenue forecast is $19.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The FMCQF stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus FMCQF price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The FMCQF short-term stock prediction for tomorrow is $46.61 (+3.20%). The FMCQF stock price prediction for 2027 estimates an average of $46. The FMCQF stock prediction for 2030 projects a range of $46–$49.
Fresenius Medical Care AG & Co. KGaA trades on OTC under the ticker FMCQF. The FMCQF stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 44% of covering analysts.
Frequently asked questions
FMCQF forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month FMCQF price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $45.17.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.